Last month, the U.S. Food and Drug Administration approved an updated COVID-19 bivalent booster, specifically to target the Omicron variant. Starting this fall, Moderna and Pfizer will offer these ...

On Monday, the U.K. became the first country to approve a bivalent vaccine booster shot for adults, which would target both the original COVID virus and the Omicron variant. This vaccine, which is ...

Booster doses of COVID-19 vaccines reduce COVID-19 infection, hospitalization, and death. The bivalent COVID-19 vaccine booster elicits a higher antibody response than the monovalent booster. By ...

COVID booster vaccinations reduced the likelihood of hospitalization related to COVID in patients with autoimmune diseases, with monovalent and bivalent booster vaccines showing 38% and 32% ...

The Centers for Disease Control and Prevention recommended Thursday that teenagers and adults get updated booster shots from Pfizer or Moderna. The shots — also known as bivalent vaccines —are ...

With the winter months and flu season ahead, it may be time to consider getting a COVID bivalent booster shot. Last month, the U.S. Centers for Disease Control and Prevention signed off on updated ...

A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.

The 70-year-old was quick to get an updated bivalent booster when they were rolled out in the US last fall. The bivalent booster is now recommended for all Americans 5 and older at least two months ...

Following a second bivalent booster, many SOTRs regained the ability to neutralize both virus strains; yet 42% did not have any detectable immunity to XBB.1.5. The researchers found that those SOTRs ...

COVID-19 boosters significantly reduce hospitalization and ICU admissions in patients with cancer, but uptake remains low, necessitating targeted interventions to improve vaccination rates. Monovalent ...

The Centers for Disease Control and Prevention (CDC) has endorsed a plan to "allow" people over age 65 and those who are immunocompromised to get a second dose of the COVID-19 bivalent booster. This ...